IBM is reaffirmed as a "Buy" with an increased price target of $280 following strong Q1 results, including 10% revenue growth, 19% EPS increase, and record free cash flow margins. Management maintains FY 2026 guidance of over 5% revenue growth and about $1 billion annual free cash flow increases, with EPS growth expected to accelerate into the mid-teens. Key risks include AI disruption, integration challenges with Confluent, and potential slowdown in the Infrastructure segment as z17 cycles mature. These results and outlook support confidence in IBM's growth trajectory amid a strong tech sector performance this year.
The Defiance Quantum Computing ETF (QTUM) has surpassed $5 billion in assets, coinciding with the US government's announcement of a historic $2 billion investment in quantum computing companies. This federal funding initiative includes major awards t...
IBM has signed a five-year global agreement with Abertis to modernize the latter's technological infrastructure by migrating to SAP S/4HANA. This upgrade aims to improve system scalability, reliability, and user experience across Abertis's operations...
The Dow Jones Industrial Average closed at a record 50,579.70, driven by optimism over progress in Iran peace talks and strong earnings reports from companies like Merck, Salesforce, and Cisco. This broad market rally included gains in healthcare, te...
